03:56 PM EST - Ondine Biopharma Corp. : signed non-binding letters of intent or LOI with a syndicate of private equity investors based in Europe. The LOIs is to purchase a majority position in Ondine's to be formed subsidiary, Sinuwave Technologies Corp., which will be dedicated to the development of photodisinfection solutions for the chronic sinusitis market. Ondine Biopharma Corp.
shares T.OBP are trading up $0.01 at $0.06.
